AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
A 2-PART PHASE-I TRIAL OF HIGH-DOSE INTERLEUKIN-2 IN COMBINATION WITHSOLUBLE (CHINESE-HAMSTER OVARY) INTERLEUKIN-1 RECEPTOR
Authors: MCDERMOTT DF TREHU EG MIER JW SORCE D RAND W RONAYNE L KAPPLER K CLANCY M KLEMPNER M ATKINS MB
Citation: Df. Mcdermott et al., A 2-PART PHASE-I TRIAL OF HIGH-DOSE INTERLEUKIN-2 IN COMBINATION WITHSOLUBLE (CHINESE-HAMSTER OVARY) INTERLEUKIN-1 RECEPTOR, Clinical cancer research, 4(5), 1998, pp. 1203-1213
A 2-PART PHASE-I TRIAL OF HIGH-DOSE INTERLEUKIN-2 IN COMBINATION WITHSOLUBLE (CHINESE-HAMSTER OVARY) INTERLEUKIN-1 RECEPTOR
Authors: MCDERMOTT DF TREHU EG MIER JW SORCE D RAND W RONAYNE L KAPPLER K CLANCY M KLEMPNER M ATKINS MB
Citation: Df. Mcdermott et al., A 2-PART PHASE-I TRIAL OF HIGH-DOSE INTERLEUKIN-2 IN COMBINATION WITHSOLUBLE (CHINESE-HAMSTER OVARY) INTERLEUKIN-1 RECEPTOR, Clinical cancer research, 4(5), 1998, pp. 1203-1213
CALPAIN REGULATED ACTIN REMODELING DURING CELL SPREADING (VOL 141, PG647, 1998)
Authors: POTTER DA TIRNAUER JS JANSSEN R CROALL DE HUGHES CN FIACCO KA MIER JW MAKI M HERMAN IM
Citation: Da. Potter et al., CALPAIN REGULATED ACTIN REMODELING DURING CELL SPREADING (VOL 141, PG647, 1998), The Journal of cell biology, 141(5), 1998, pp. 1289-1289
CALPAIN REGULATES ACTIN REMODELING DURING CELL SPREADING
Authors: POTTER DA TIRNAUER JS JANSSEN R CROALL DE HUGHES CN FIACCO KA MIER JW MAKI M HERMAN IM
Citation: Da. Potter et al., CALPAIN REGULATES ACTIN REMODELING DURING CELL SPREADING, The Journal of cell biology, 141(3), 1998, pp. 647-662
RAS-INDUCED AND RAF-INDUCED DOWN-MODULATION OF NONMUSCLE TROPOMYOSIN ARE MEK-INDEPENDENT
Authors: JANSSEN RAJ VEENSTRA KG JONASCH P JONASCH E MIER JW
Citation: Raj. Janssen et al., RAS-INDUCED AND RAF-INDUCED DOWN-MODULATION OF NONMUSCLE TROPOMYOSIN ARE MEK-INDEPENDENT, The Journal of biological chemistry, 273(48), 1998, pp. 32182-32186
PHASE-I EVALUATION OF INTRAVENOUS RECOMBINANT HUMAN INTERLEUKIN-12 INPATIENTS WITH ADVANCED MALIGNANCIES
Authors: ATKINS MB ROBERTSON MJ GORDON M LOTZE MT DECOSTE M DUBOIS JS RITZ J SANDLER AB EDINGTON HD GARZONE PD MIER JW CANNING CM BATTIATO L TAHARA H SHERMAN ML
Citation: Mb. Atkins et al., PHASE-I EVALUATION OF INTRAVENOUS RECOMBINANT HUMAN INTERLEUKIN-12 INPATIENTS WITH ADVANCED MALIGNANCIES, Clinical cancer research, 3(3), 1997, pp. 409-417
TROPOMYOSIN-2 CDNA LACKING THE 3'-UNTRANSLATED REGION RIBOREGULATOR INDUCES GROWTH-INHIBITION OF V-KI-RAS-TRANSFORMED FIBROBLASTS
Authors: JANSSEN RAJ MIER JW
Citation: Raj. Janssen et Jw. Mier, TROPOMYOSIN-2 CDNA LACKING THE 3'-UNTRANSLATED REGION RIBOREGULATOR INDUCES GROWTH-INHIBITION OF V-KI-RAS-TRANSFORMED FIBROBLASTS, Molecular biology of the cell, 8(5), 1997, pp. 897-908
RANDOMIZED PLACEBO-CONTROLLED CLINICAL-TRIAL OF HIGH-DOSE INTERLEUKIN-2 IN COMBINATION WITH A SOLUBLE P75 TUMOR-NECROSIS-FACTOR RECEPTOR IMMUNOGLOBULIN-G CHIMERA IN PATIENTS WITH ADVANCED MELANOMA AND RENAL-CELL CARCINOMA
Authors: DUBOIS JS TREHU EG MIER JW SHAPIRO L EPSTEIN M KLEMPNER M DINARELLO C KAPPLER K RONAYNE L RAND W ATKINS MB
Citation: Js. Dubois et al., RANDOMIZED PLACEBO-CONTROLLED CLINICAL-TRIAL OF HIGH-DOSE INTERLEUKIN-2 IN COMBINATION WITH A SOLUBLE P75 TUMOR-NECROSIS-FACTOR RECEPTOR IMMUNOGLOBULIN-G CHIMERA IN PATIENTS WITH ADVANCED MELANOMA AND RENAL-CELL CARCINOMA, Journal of clinical oncology, 15(3), 1997, pp. 1052-1062
PHASE-I TRIAL OF INTERLEUKIN-2 IN COMBINATION WITH THE SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR P75 IGG CHIMERA
Authors: TREHU EG MIER JW DUBOIS JS SORCE D KLEMPNER MS EPSTEIN M DINARELLO CA SHAPIRO L KAPPLER K RONAYNE L ATKINS MB
Citation: Eg. Trehu et al., PHASE-I TRIAL OF INTERLEUKIN-2 IN COMBINATION WITH THE SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR P75 IGG CHIMERA, Clinical cancer research, 2(8), 1996, pp. 1341-1351
L-SELECTIN CROSS-LINKING INDUCES INTEGRIN-DEPENDENT ADHESION - EVIDENCE FOR A SIGNALING PATHWAY INVOLVING PTK BUT NOT PKC
Authors: SIKORSKI MA STAUNTON DE MIER JW
Citation: Ma. Sikorski et al., L-SELECTIN CROSS-LINKING INDUCES INTEGRIN-DEPENDENT ADHESION - EVIDENCE FOR A SIGNALING PATHWAY INVOLVING PTK BUT NOT PKC, Cell adhesion and communication, 4(4-5), 1996, pp. 355-367
PROTEASE-RESISTANT L-SELECTIN MUTANTS - DOWN-MODULATION BY CROSS-LINKING BUT NOT CELLULAR ACTIVATION
Authors: STODDART JH JASUJA RR SIKORSKI MA VONANDRIAN UH MIER JW
Citation: Jh. Stoddart et al., PROTEASE-RESISTANT L-SELECTIN MUTANTS - DOWN-MODULATION BY CROSS-LINKING BUT NOT CELLULAR ACTIVATION, The Journal of immunology, 157(12), 1996, pp. 5653-5659
CALPAIN REGULATES FUNCTION AND MORPHOLOGY OF THE ACTIN CYTOSKELETON
Authors: TIRNAUER JS JANSSEN R HUGHES CN MIER JW CROALL DE MAKI M HERMAN IM POTTER DA
Citation: Js. Tirnauer et al., CALPAIN REGULATES FUNCTION AND MORPHOLOGY OF THE ACTIN CYTOSKELETON, Blood, 88(10), 1996, pp. 74-74
INDUCTION OF CIRCULATING INTERLEUKIN-10 BY INTERLEUKIN-1 AND INTERLEUKIN-2, BUT NOT INTERLEUKIN-6 IMMUNOTHERAPY
Authors: TILG H ATKINS MB DINARELLO CA MIER JW
Citation: H. Tilg et al., INDUCTION OF CIRCULATING INTERLEUKIN-10 BY INTERLEUKIN-1 AND INTERLEUKIN-2, BUT NOT INTERLEUKIN-6 IMMUNOTHERAPY, Cytokine, 7(7), 1995, pp. 734-739
EFFECTS OF MALIGNANCY AND INTERLEUKIN-2 INFUSION ON GUT MACROMOLECULAR PERMEABILITY
Authors: RYAN CM ATKINS MB MIER JW GELFAND JA TOMPKINS RG
Citation: Cm. Ryan et al., EFFECTS OF MALIGNANCY AND INTERLEUKIN-2 INFUSION ON GUT MACROMOLECULAR PERMEABILITY, Critical care medicine, 23(11), 1995, pp. 1801-1806
INTERLEUKIN-6-ASSOCIATED ANEMIA - DETERMINATION OF THE UNDERLYING MECHANISM
Authors: ATKINS MB KAPPLER K MIER JW ISAACS RE BERKMAN EM
Citation: Mb. Atkins et al., INTERLEUKIN-6-ASSOCIATED ANEMIA - DETERMINATION OF THE UNDERLYING MECHANISM, Blood, 86(4), 1995, pp. 1288-1291
PHASE-II TRIALS OF HIGH-DOSE INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED BREAST-CARCINOMA AND CARCINOMA OF THE LUNG, OVARY, AND PANCREAS AND OTHER TUMORS
Authors: SPARANO JA FISHER RI WEISS GR MARGOLIN K ARONSON FR HAWKINS MJ ATKINS MB DUTCHER JP GAYNOR ER BOLDT DH DOROSHOW JH ERNEST ML SZNOL M MIER JW
Citation: Ja. Sparano et al., PHASE-II TRIALS OF HIGH-DOSE INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED BREAST-CARCINOMA AND CARCINOMA OF THE LUNG, OVARY, AND PANCREAS AND OTHER TUMORS, Journal of immunotherapy with emphasis on tumor immunology, 16(3), 1994, pp. 216-223
PHASE-II STUDIES OF RECOMBINANT HUMAN INTERLEUKIN-4 IN ADVANCED RENAL-CANCER AND MALIGNANT-MELANOMA
Authors: MARGOLIN K ARONSON FR SZNOL M ATKINS MB GUCALP R FISHER RI SUNDERLAND M DOROSHOW JH ERNEST ML MIER JW DUTCHER JP GAYNOR ER WEISS GR
Citation: K. Margolin et al., PHASE-II STUDIES OF RECOMBINANT HUMAN INTERLEUKIN-4 IN ADVANCED RENAL-CANCER AND MALIGNANT-MELANOMA, Journal of immunotherapy with emphasis on tumor immunology, 15(2), 1994, pp. 147-153
INDUCTION OF CIRCULATING SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR AND INTERLEUKIN-1 RECEPTOR ANTAGONIST FOLLOWING INTERLEUKIN-1-ALPHA INFUSION IN HUMANS
Authors: TILG H TREHU E SHAPIRO L PAPE D ATKINS MB DINARELLO CA MIER JW
Citation: H. Tilg et al., INDUCTION OF CIRCULATING SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR AND INTERLEUKIN-1 RECEPTOR ANTAGONIST FOLLOWING INTERLEUKIN-1-ALPHA INFUSION IN HUMANS, Cytokine, 6(2), 1994, pp. 215-219
MULTIINSTITUTIONAL PHASE-II TRIAL OF INTENSIVE COMBINATION CHEMOIMMUNOTHERAPY FOR METASTATIC MELANOMA
Authors: ATKINS MB OBOYLE KR SOSMAN JA WEISS GR MARGOLIN KA ERNEST ML KAPPLER K MIER JW SPARANO JA FISHER RI ECKARDT JR PEREIRA C ARONSON FR
Citation: Mb. Atkins et al., MULTIINSTITUTIONAL PHASE-II TRIAL OF INTENSIVE COMBINATION CHEMOIMMUNOTHERAPY FOR METASTATIC MELANOMA, Journal of clinical oncology, 12(8), 1994, pp. 1553-1560
INDUCTION OF CIRCULATING ANTAGONISTS TO IL-1 AND TNF BY IL-2 ADMINISTRATION AND THEIR EFFECTS ON IL-2-INDUCED CYTOKINE PRODUCTION IN-VITRO
Authors: TILG H SHAPIRO L VANNIER E POUTSIAKA DD TREHU E ATKINS MB DINARELLO CA MIER JW
Citation: H. Tilg et al., INDUCTION OF CIRCULATING ANTAGONISTS TO IL-1 AND TNF BY IL-2 ADMINISTRATION AND THEIR EFFECTS ON IL-2-INDUCED CYTOKINE PRODUCTION IN-VITRO, The Journal of immunology, 152(6), 1994, pp. 3189-3198
INTERLEUKIN-6 (IL-6) AS AN ANTIINFLAMMATORY CYTOKINE - INDUCTION OF CIRCULATING IL-1-RECEPTOR ANTAGONIST AND SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR-P55
Authors: TILG H TREHU E ATKINS MB DINARELLO CA MIER JW
Citation: H. Tilg et al., INTERLEUKIN-6 (IL-6) AS AN ANTIINFLAMMATORY CYTOKINE - INDUCTION OF CIRCULATING IL-1-RECEPTOR ANTAGONIST AND SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR-P55, Blood, 83(1), 1994, pp. 113-118
POSSIBLE MYOCARDIAL TOXICITY ASSOCIATED WITH INTERLEUKIN-4 THERAPY
Authors: TREHU EG ISNER JM MIER JW KARP DD ATKINS MB
Citation: Eg. Trehu et al., POSSIBLE MYOCARDIAL TOXICITY ASSOCIATED WITH INTERLEUKIN-4 THERAPY, Journal of immunotherapy with emphasis on tumor immunology, 14(4), 1993, pp. 348-351
RANDOMIZED PHASE-III TRIAL OF TREATMENT WITH HIGH-DOSE INTERLEUKIN-2 EITHER ALONE OR IN COMBINATION WITH INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED MELANOMA
Authors: SPARANO JA FISHER RI SUNDERLAND M MARGOLIN K ERNEST ML SZNOL M ATKINS MB DUTCHER JP MICETICH KC WEISS GR DOROSHOW JH ARONSON FR RUBINSTEIN LV MIER JW
Citation: Ja. Sparano et al., RANDOMIZED PHASE-III TRIAL OF TREATMENT WITH HIGH-DOSE INTERLEUKIN-2 EITHER ALONE OR IN COMBINATION WITH INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED MELANOMA, Journal of clinical oncology, 11(10), 1993, pp. 1969-1977
CULTURED HUMAN ENDOTHELIAL-CELLS EXPRESS THE 140-KD ISOFORM OF NEURALCELL-ADHESION MOLECULE (NCAM)
Authors: BRANDON EP KOTIK AN VACHINO G SWACK JA LIBBY P JANICKA MW ATKINS MB MIER JW
Citation: Ep. Brandon et al., CULTURED HUMAN ENDOTHELIAL-CELLS EXPRESS THE 140-KD ISOFORM OF NEURALCELL-ADHESION MOLECULE (NCAM), International journal of immunopathology and pharmacology, 6(2), 1993, pp. 77-84
INDUCTION OF CIRCULATING AND ERYTHROCYTE-BOUND IL-8 BY IL-2 IMMUNOTHERAPY AND SUPPRESSION OF ITS IN-VITRO PRODUCTION BY IL-1-RECEPTOR ANTAGONIST AND SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR (P75) CHIMERA
Authors: TILG H SHAPIRO L ATKINS MB DINARELLO CA MIER JW
Citation: H. Tilg et al., INDUCTION OF CIRCULATING AND ERYTHROCYTE-BOUND IL-8 BY IL-2 IMMUNOTHERAPY AND SUPPRESSION OF ITS IN-VITRO PRODUCTION BY IL-1-RECEPTOR ANTAGONIST AND SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR (P75) CHIMERA, The Journal of immunology, 151(6), 1993, pp. 3299-3307
Risultati: 1-25 | 26-30